SULFADOXINE, 500mg / PYRIMETHAMINE, 25mg, tab.
STD
DORASULP5T-
Valid Article
Account code:
60000
HS Code:
300460
Last Updated on:
04/06/2025, 08:10:11
Former
Code(s):
-X
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
P01BD51
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
SULFADOXINE / PYRIMETHAMINE (SP) pregnancy
Therapeutic Action
Fixed-dose combination (FDC) of two antimalarials
Indications
Instructions for use
The 500mg dispersible tablet is preferred to the normal 500mg tablet.
Resistance to sulfadoxine/pyrimethamine is becoming more and more frequent.
Precautions for Use
Contraindicated during the first trimester of pregnancy due to the risk of neural tube defects.
Do not use in combination with co-trimoxazole.
The dosage Sulfadoxine 250mg / Pyrimethamine 12.5mg is reserved for the Perennial Malaria Chemoprevention - PMC (formerly called SP-IPTi) in children under 24 months of age.
Storage
Below 25°C ‐ Protect from sunlight